Management of tumour spillage during parotid surgery for pleomorphic adenoma


      Over the decades parotid surgery for benign tumours has developed into a reproducible, conservative operation with low morbidity. Despite the advances tumour spillage can still occur, and its management remains controversial. Since no universal consensus exists the aim of this article is to review the approach to tumour spillage and derive a protocol for its management based on existing evidence.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to British Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Pinkston J.A.
        • Cole P.
        Incidence rates of salivary gland tumors: results from a population-based study.
        Otolaryngol Head Neck Surg. 1999; 120: 834-840
        • Zbären P.
        • Stauffer E.
        Pleomorphic adenoma of the parotid gland: histopathologic analysis of the capsular characteristics of 218 tumors.
        Head Neck. 2007; 29: 751-757
        • Witt R.L.
        The significance of the margin in parotid surgery for pleomorphic adenoma.
        Laryngoscope. 2002; 112: 2141-2154
        • Buchman C.
        • Stringer S.P.
        • Mendenhall W.M.
        • et al.
        Pleomorphic adenoma: effect of tumor spill and inadequate resection on tumor recurrence.
        Head Neck. 1994; 104: 1231-1234
        • Natvig K.
        • Søberg R.
        Relationship of intraoperative rupture of pleomorphic adenomas to recurrence: an 11-25 year follow-up study.
        Head Neck. 1994; 16: 213-217
        • Henriksson G.
        • Westrin K.M.
        • Carlsöö B.
        • et al.
        Recurrent primary pleomorphic adenomas of salivary gland origin: intrasurgical rupture, histopathologic features, and pseudopodia.
        Cancer. 1998; 82: 617-620
        • Barton J.
        • Slevin N.J.
        • Gleave E.N.
        Radiotherapy for pleomorphic adenoma of the parotid gland.
        Int J Radiat Oncol Biol Phys. 1992; 22: 925-928
        • Ravasz L.A.
        • Hordijk G.J.
        • Terhaard C.H.
        Is there a role for radiotherapy in the treatment of patients with pleomorphic adenoma of the parotid gland?.
        Ned Tijdschr Geneeskd. 1989; 133 ([In Dutch]): 2129-2132
        • Makeieff M.
        • Pelliccia P.
        • Letois F.
        • et al.
        Recurrent pleomorphic adenoma: results of surgical treatment.
        Ann Surg Oncol. 2010; 17: 3308-3313
        • Rowley H.
        • Murphy M.
        • Smyth D.
        • et al.
        Recurrent pleomorphic adenoma: uninodular versus multinodular disease.
        Ir J Med Sci. 2000; 169: 201-203
        • Szwedowicz P.
        • Osuch-Wójcikiewicz E.
        • Bruzgielewicz A.
        • et al.
        Management of recurrent pleomorphic adenoma of the parotid gland: analysis of the material of Otolaryngology Department, Medical University of Warsaw between 1998 and 2008.
        Otolaryngol Pol. 2010; 64 ([In Polish]): 50-54
        • Stennert E.
        • Wittekindt C.
        • Klussmann J.P.
        • et al.
        Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study.
        Laryngoscope. 2004; 114: 158-163
        • Wittekindt C.
        • Streubel K.
        • Arnold G.
        • et al.
        Recurrent pleomorphic adenoma of the parotid gland: analysis of 108 consecutive patients.
        Head Neck. 2007; 29: 822-828
        • Samson M.J.
        • Metson R.
        • Wang C.C.
        • et al.
        Preservation of the facial nerve in the management of recurrent pleomorphic adenoma.
        Laryngoscope. 1991; 101: 1060-1062
        • Phillips P.P.
        • Olsen K.D.
        Recurrent pleomorphic adenoma of the parotid gland: report of 126 cases and a review of the literature.
        Ann Otol Rhinol Laryngol. 1995; 104: 100-104
        • Douglas J.G.
        • Einck J.
        • Austin-Seymour M.
        • et al.
        Neutron radiotherapy for recurrent pleomorphic adenomas of major salivary glands.
        Head Neck. 2001; 23: 1037-1042
        • Donovan D.T.
        • Conley J.J.
        Capsular significance in parotid tumor surgery: reality and myths of lateral lobectomy.
        Laryngoscope. 1984; 94: 324-329
        • McGurk M.
        • Renehan A.
        • Gleave E.N.
        • et al.
        Clinical significance of the tumour capsule in the treatment of parotid pleomorphic adenomas.
        Br J Surg. 1996; 83: 1747-1749
        • Alajmo E.
        • Polli G.
        • De Meester W.
        Total parotidectomy – a routine treatment for parotid gland swellings?.
        J Laryngol Otol. 1989; 103: 181-186
        • Watkin G.T.
        • Hobsley M.
        Influence of local surgery and radiotherapy on the natural history of pleomorphic adenomas.
        Br J Surg. 1986; 73: 74-76
        • Renehan A.
        • Gleave E.N.
        • McGurk M.
        An analysis of the treatment of 114 patients with recurrent pleomorphic adenomas of the parotid gland.
        Am J Surg. 1996; 172: 710-714